2022年10月14日 星期五

102議題之"at once envisage" - MPEP 2131.02(III)筆記

本篇延續之前報導(新穎性中的“at once envisage”原則討論 - Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp. (Fed. Cir. 2022)(https://enpan.blogspot.com/2022/10/at-once-envisage-mylan-pharms-inc-v.html)中討論的"at once envisage"(我是翻譯"立即設想")。

根據MPEP 2131新穎性審查指南(https://www.uspto.gov/web/offices/pac/mpep/s2131.html)中的2131.02 III的描述,當有種類(species,屬於下位概念的特徵)可以從揭露內容"立即設想(at once envisaged)"時,其一般描述將可預期揭露內容所涵蓋的主張權利的物種。

(編按,根據初步理解,這句話表示,當有特徵可以一眼看出,表示一般的揭露已經可以涵蓋到此特定特徵,這在本章新穎性是很重要的概念。就生物分類而言,"genus"稱"屬","species"稱"種",genus涵蓋species。)

重點整理:
  • 即便參考文獻沒有描述權利範圍中的元件的安排或組合,如果相關領域技術人員閱讀此參考文獻可以"立即設想"權利範圍中的安排或組合時,表示此參考文獻可以預期 (anticipate)此項專利範圍。(編按,這如一般常說的即便沒有揭露但卻無歧異得知,這仍是新穎性的範疇)

  • 相關案例是Kennametal, Inc. v. Ingersoll Cutting Tool Co.(https://cafc.uscourts.gov/opinions-orders/14-1350.opinion.3-23-2015.1.pdf
  • Kennametal案中,引證文獻揭示了很多材料與塗佈方法的組合可能性,使得法院判決系爭專利已經讓相關領域技術人員可以"at once envisage"系爭專利範圍中的特定組合,不具新穎性。
  • "The Federal Circuit stated that the reference’s "express ‘contemplation’ of PVD coatings provided sufficient evidence that a reasonable mind could find that a person of skill in the art… would immediately envisage applying a PVD coating."(聯邦巡迴法院在Kennametal判決:先前技術(即便有多種排列組合)表達出使用PVD塗佈方法的意圖(有意圖即可),已是足夠的證據證明相關領域技術人員可以立即設想到使用PVD塗佈方法。)

  • 案例可參考:未被揭露但因“at once envisage”而不具新穎性案例討論 - Kennametal, Inc. v. Ingersoll Cutting Tool Co. (Fed. Cir. 2015)https://enpan.blogspot.com/2022/10/at-once-envisage-kennametal-inc-v.html

-------MPEP 2131.02 III--------------------

2131 Anticipation — Application of 35 U.S.C. 102

2131.02 Genus-Species Situations

III. A GENERIC DISCLOSURE WILL ANTICIPATE A CLAIMED SPECIES COVERED BY THAT DISCLOSURE WHEN THE SPECIES CAN BE "AT ONCE ENVISAGED" FROM THE DISCLOSURE


"[W]hether a generic disclosure necessarily anticipates everything within the genus … depends on the factual aspects of the specific disclosure and the particular products at issue." Sanofi-Synthelabo v. Apotex, Inc., 550 F.3d 1075, 1083, 89 USPQ2d 1370, 1375 (Fed. Cir. 2008). See also Osram Sylvania Inc. v. American Induction Tech. Inc., 701 F.3d 698, 706, 105 USPQ2d 1368, 1374 (Fed. Cir. 2012) ("how one of ordinary skill in the art would understand the relative size of a genus or species in a particular technology is of critical importance").

A reference disclosure can anticipate a claim even if the reference does not describe "the limitations arranged or combined as in the claim, if a person of skill in the art, reading the reference, would ‘at once envisage’ the claimed arrangement or combination." Kennametal, Inc. v. Ingersoll Cutting Tool Co., 780 F.3d 1376, 1381, 114 USPQ2d 1250, 1254 (Fed. Cir. 2015) (quoting In re Petering, 301 F.2d 676, 681(CCPA 1962)). In Kennametal, the challenged claim was to a cutting tool requiring a ruthenium binding agent with a physical vapor deposition (PVD) coating. Claim 5 of the reference disclosed all the elements of the claimed coated cutting tool, however, ruthenium was one of five specified binding agents and the claim did not specify a particular coating technique. The specification of the reference disclosed PVD as one of three suitable coating techniques. The Federal Circuit stated that the reference’s "express ‘contemplat[ion]’ of PVD coatings provided sufficient evidence that a reasonable mind could find that a person of skill in the art… would immediately envisage applying a PVD coating. Thus, substantial evidence supports the Board's conclusion that [the reference] effectively teaches 15 combinations, of which one anticipates pending claim 1. Though it is true that there is no evidence in [the reference] of ‘actual performance’ of combining the ruthenium binder and PVD coatings, this is not required." Kennametal, 780 F.3d at 1383, 114 USPQ2d at 1255 (citations omitted).

When a claimed compound is not specifically named in a reference, but instead it is necessary to select portions of teachings within the reference and combine them, e.g., select various substituents from a list of alternatives given for placement at specific sites on a generic chemical formula to arrive at a specific composition, anticipation can only be found if the classes of substituents are sufficiently limited or well delineated. Ex parte A, 17 USPQ2d 1716 (Bd. Pat. App. & Inter. 1990). If one of ordinary skill in the art is able to "at once envisage" the specific compound within the generic chemical formula, the compound is anticipated. One of ordinary skill in the art must be able to draw the structural formula or write the name of each of the compounds included in the generic formula before any of the compounds can be "at once envisaged." One may look to the preferred embodiments to determine which compounds can be anticipated. In re Petering, 301 F.2d 676, 133 USPQ 275 (CCPA 1962).

In In re Petering, the prior art disclosed a generic chemical formula "wherein X, Y, Z, P, and R'- represent either hydrogen or alkyl radicals, R a side chain containing an OH group." The court held that this formula, without more, could not anticipate a claim to 7-methyl-9-[d, l'-ribityl]-isoalloxazine because the generic formula encompassed a vast number and perhaps even an infinite number of compounds. However, the reference also disclosed preferred substituents for X, Y, Z, P, R, and R' as follows: where X, P, and R' are hydrogen, where Y and Z may be hydrogen or methyl, and where R is one of eight specific isoalloxazines. The court determined that this more limited generic class consisted of about 20 compounds. The limited number of compounds covered by the preferred formula in combination with the fact that the number of substituents was low at each site, the ring positions were limited, and there was a large unchanging structural nucleus, resulted in a finding that the reference sufficiently described "each of the various permutations here involved as fully as if he had drawn each structural formula or had written each name." The claimed compound was 1 of these 20 compounds. Therefore, the reference "described" the claimed compound and the reference anticipated the claims.

In In re Schauman, 572 F.2d 312, 197 USPQ 5 (CCPA 1978), claims to a specific compound were anticipated because the prior art taught a generic formula embracing a limited number of compounds closely related to each other in structure and the properties possessed by the compound class of the prior art was that disclosed for the claimed compound. The broad generic formula seemed to describe an infinite number of compounds but claim 1 was limited to a structure with only one variable substituent R. This substituent was limited to low alkyl radicals. One of ordinary skill in the art would at once envisage the subject matter within claim 1 of the reference.

Compare In re Meyer, 599 F.2d 1026, 202 USPQ 175 (CCPA 1979) (A reference disclosing "alkaline chlorine or bromine solution" embraces a large number of species and cannot be said to anticipate claims to "alkali metal hypochlorite."); Akzo N.V.v.International Trade Comm’n, 808 F.2d 1471, 1 USPQ2d 1241 (Fed. Cir. 1986) (Claims to a process for making aramid fibers using a 98% solution of sulfuric acid were not anticipated by a reference which disclosed using sulfuric acid solution but which did not disclose using a 98% concentrated sulfuric acid solution.). See MPEP § 2144.08 for a discussion of obviousness in genus-species situations.


Ron 

沒有留言: